Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, announced a study revealing that more patients completed hereditary cancer testing when they used an online ...

A new NHS genetic testing programme has identified hundreds of people with Jewish ancestry at increased risk of cancer ...

Genetic testing involves the detection of specific alleles, mutations, genotypes or karyotypes that are associated with heritable traits, diseases or predispositions to disease for the individual ...

Myriad Genetics faces a tough year ahead with new policy changes. Learn why MYGN stock has cratered and if it's poised for ...

Myriad Genetics enters into an agreement with Hannah Storm, who will be the Myriad Genetics Breast Cancer Risk Assessment Program ambassador.

MyRisk with RiskScore provides eligible patients with a five-year and remaining lifetime breast cancer risk assessment individualized to them. Myriad Genetics is a leading genetic testing and ...

As per the deal, Storm will act as an ambassador for the Myriad Genetics Breast Cancer Risk Assessment Program featuring the MyRisk with RiskScore Hereditary Cancer Test, hereditary cancer test ...

(RTTNews) - Myriad Genetics Inc. (MYGN) announced an agreement with Hannah Storm, a nationally renowned sports broadcaster, who recently revealed her battle with breast cancer. As per the deal ...

Storm is a longtime SportsCenter anchor and NBC sports anchor, and host of the podcast“NBA DNA with Hannah Storm.” Her world changed in January 2024, when she was diagnosed with stage zero Ductal ...

As an ambassador for Myriad's Breast Cancer Risk Assessment Program, Storm will promote the MyRisk® with RiskScore® Hereditary Cancer Test, which evaluates genetic risks for various cancers.

"I just wish someone had told me this was a possibility." Kara Maxwell distinctly remembers the moment she heard those words ...